A Study of GPC3-targeted T Cells by Intratumor Injection for Advanced HCC (GPC3-CART)
Clinical trial NCT03130712 · UNKNOWN
Trial details
- NCT number
- NCT03130712
- Sponsor
- Shanghai GeneChem Co., Ltd.
- Status
- UNKNOWN
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-04-01
- Primary completion
- 2018-03-31
- Enrollment
- 10
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.